Explore
Validate
LearnABIN500774
antibody from antibodies-online
Targeting: SLPI
ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN500774 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Secretory Leukocyte Peptidase Inhibitor (SLPI) (Center) antibody
- Antibody type
- Polyclonal
- Antigen
- SLPI antibody was raised against a 17 amino acid peptide from near the center of human SLPI.
- Description
- Peptide affinity chromatography
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Epitope
- Center
- Isotype
- IgG
- Vial size
- 0.1 mg
- Storage
- Store at 2 - 8°C for up to one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.
Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding.
Antimicrobial peptides: mediators of innate immunity as templates for the development of novel anti-infective and immune therapeutics.
Expression of the secretory leukoprotease inhibitor gene in epithelial cells.
Jana NK, Gray LR, Shugars DC
Journal of virology 2005 May;79(10):6432-40
Journal of virology 2005 May;79(10):6432-40
Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding.
Taggart CC, Cryan SA, Weldon S, Gibbons A, Greene CM, Kelly E, Low TB, O'neill SJ, McElvaney NG
The Journal of experimental medicine 2005 Dec 19;202(12):1659-68
The Journal of experimental medicine 2005 Dec 19;202(12):1659-68
Antimicrobial peptides: mediators of innate immunity as templates for the development of novel anti-infective and immune therapeutics.
Hiemstra PS, Fernie-King BA, McMichael J, Lachmann PJ, Sallenave JM
Current pharmaceutical design 2004;10(23):2891-905
Current pharmaceutical design 2004;10(23):2891-905
Expression of the secretory leukoprotease inhibitor gene in epithelial cells.
Abe T, Kobayashi N, Yoshimura K, Trapnell BC, Kim H, Hubbard RC, Brewer MT, Thompson RC, Crystal RG
The Journal of clinical investigation 1991 Jun;87(6):2207-15
The Journal of clinical investigation 1991 Jun;87(6):2207-15
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Western blot analysis of SLPI in Daudi cell lysate with AP30810PU-N at (A) 1 and (B) 2 ?g/ml.
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Immunohistochemistry of SLPI in mouse lung tissue with AP30810PU-N at 10 ?g/ml.
